Regional guidelines for continuing medical education (CME/continuing professional development (CPD) activities
AbstractContinuing Medical Education (CME) is a process of continuous learning by which medical professionals keep themselves updated through acquisition of new knowledge, skills and attitudes to maintain professional competency, in-patient management, health services management (including organizing teaching) and their own professional development. Over the years, the scope of CME has broadened from mere clinical updates to a wide-ranging "continuing professional development" that includes behavioural change, social and managerial skills and the multidisciplinary context of patient care. Designing good-quality CME and continuing professional development programmes appropriate to the needs of different types and categories of health and allied professionals will, however, remain a big challenge and would need to be addressed through national mechanisms.. There is therefore a need to develop comprehensive guidelines for countries in the South-East Asia Region on CME/CPD activities that would look at (i) processes and operational mechanisms; (ii) identifying accreditation bodies for CME programmes and credit allocation; and (iii) identifying appropriate institutes in developing and conducting need-based CME /CPD programmes. These guidelines, after adaptation, should help countries in the Region in strengthening their CME/CPD activities.
World Health Organization, Regional Office for South-East Asia. (2010). Regional guidelines for continuing medical education (CME/continuing professional development (CPD) activities. WHO Regional Office for South-East Asia. http://www.who.int/iris/handle/10665/205767
Gov't Doc #SEA-HSD-334
MetadataShow full item record
Showing items related by title and MeSH subject.
Two AIDS medicines back on WHO prequalification list : Generic manufacturers continue to upgrade their practices = Retour de deux médicaments antiSIDA sur la liste des médicaments préselectionnés de l’OMS : Les fabricants de génériques continuent d’améliorer leurs pratiques World Health Organization (2004)